PubMed · 16395484
[Fibrinolytic therapy].
Abstract
Fibrinolytic therapy still is a keystone in the therapeutic approach of acute occlusion in different vascular regions. However, before starting fibrinolytic therapy an evidence-based risk assessment is necessary. This article presents the most common fibrinolytic agents as well as evidences and recommendations for fibrinolytic therapy of different vascular regions.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
J Beyer, S Schellong. 2005. [Fibrinolytic therapy].. https://pubmed.ncbi.nlm.nih.gov/16395484/
Cite the original work for its findings. Save a collection to share your selection of sources.